Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

被引:690
作者
Allan, Sarah E.
Crome, Sarah Q.
Crellin, Natasha K.
Passerini, Laura
Steiner, Theodore S.
Bacchetta, Rosa
Roncarolo, Maria G.
Levings, Megan K.
机构
[1] Univ British Columbia, Dept Surg, Vancouver, BC, Canada
[2] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada
[3] San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy
[4] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[5] Univ Vita Salute San Raffaele, Milan, Italy
关键词
human; T cells; T cell activation; tolerance; transcription factors;
D O I
10.1093/intimm/dxm014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 40 条
  • [1] The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
    Allan, SE
    Passerini, L
    Bacchetta, R
    Crellin, N
    Dai, MY
    Orban, PC
    Ziegler, SF
    Roncarolo, MG
    Levings, MK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) : 3276 - 3284
  • [2] Defective regulatory and effector T cell functions in patients with FOXP3 mutations
    Bacchetta, Rosa
    Passerini, Laura
    Gambineri, Eleonora
    Dai, Minyue
    Allan, Sarah E.
    Perroni, Lucia
    Dagna-Bricarelli, Franca
    Sartirana, Claudia
    Matthes-Martins, Susanne
    Lawitschka, Anita
    Azzari, Chiara
    Ziegler, Steven F.
    Levings, Megan K.
    Roncarolo, Maria Grazia
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (06) : 1713 - 1722
  • [3] Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation
    Chen, Chunxia
    Rowell, Emily A.
    Thomas, Rajan M.
    Hancock, Wayne W.
    Wells, Andrew D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) : 36828 - 36834
  • [4] Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
    Chen, WJ
    Jin, WW
    Hardegen, N
    Lei, KJ
    Li, L
    Marinos, N
    McGrady, G
    Wahl, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) : 1875 - 1886
  • [5] Clark LB, 1999, J IMMUNOL, V162, P2546
  • [6] Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells
    Crellin, NK
    Garcia, RV
    Hadisfar, O
    Allan, SE
    Steiner, TS
    Levings, MK
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (12) : 8051 - 8059
  • [7] High throughput methods for gene cloning and expression
    Dieckman, L
    Gu, MY
    Stols, L
    Donnelly, MI
    Collart, FR
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (01) : 1 - 7
  • [8] Alternate signalling pathways from the interleukin-2 receptor
    Ellery, JM
    Nicholls, PJ
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) : 27 - 40
  • [9] Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
    Fontenot, JD
    Rasmussen, JP
    Williams, LM
    Dooley, JL
    Farr, AG
    Rudensky, AY
    [J]. IMMUNITY, 2005, 22 (03) : 329 - 341
  • [10] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992